 | Up a level |
Journal Article
Dietlein, F., Kalb, B., Jokic, M., Torgovnick, A., Schmitt, A., Buettner, R., Thomas, R. and Reinhardt, H. C. (2015). Combined Chk1-and MK2-inhibition displays robust synergy in KRAS-mutant cancer. Oncol. Res. Treat., 38. S. 169 - 170. BASEL: KARGER. ISSN 2296-5262
Riabinska, A., Schmitt, A., Fritz, C., Knittel, G., Torgovnick, A., Heneweer, C., Wittersheim, M., Frenzel, L., Wunderlich, C., Jachimowicz, R., Merseburg, A., Persigehl, T., Wunderlich, T., Buettner, R. and Reinhardt, H. C. (2017). Restoration of Atm induces lymphoma regression in vivo and is mediated by cell autonomous and non-cell autonomous mechanisms. Oncol. Res. Treat., 40. S. 40 - 41. BASEL: KARGER. ISSN 2296-5262
Schmitt, A., Knittel, G., Welcker, D., Yang, T. -P., George, J., Nowak, M., Leeser, U., Buettner, R., Perner, S., Peifer, M. and Reinhardt, H. C. (2017). ATM deficiency is associated with sensitivity to PARP1-and ATR inhibitors in lung adenocarcinoma. Oncol. Res. Treat., 40. S. 247 - 248. BASEL: KARGER. ISSN 2296-5262
Zaeske, H., Degner, D., Jockers-Scheruebl, M., Klingberg, S., Klosterkoetter, J., Maier, W., Moller, H-J., Sauer, H., Schmitt, A. and Gaebel, W. (2016). Experiences of stigma and discrimination in patients with first-episode schizophrenia. Nervenarzt, 87 (1). S. 82 - 88. NEW YORK: SPRINGER. ISSN 1433-0407